Literature DB >> 23390245

An end to the myth: there is no drug development pipeline.

Kristin Baxter1, Elizabeth Horn, Neely Gal-Edd, Kristi Zonno, James O'Leary, Patrick F Terry, Sharon F Terry.   

Abstract

A new map is presented for creating an open, collaborative, and coordinated system for drug development.

Mesh：

Year:  2013        PMID： 23390245     DOI： 10.1126/scitranslmed.3003505

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  14 in total

1.  Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational Research.

Authors:  Kelly A Edwards; Sharon F Terry; Dana Gold; Elizabeth J Horn; Mary Schwartz; Molly Stuart; Suzanne D Vernon
Journal:  Biopreserv Biobank       Date:  2016-04-08       Impact factor: 2.300

2.  Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.

Authors:  Margaret C Grabb; Alan J Cross; William Z Potter; James T McCracken
Journal:  J Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.153

Review 3.  CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?

Authors:  Amey Dhopeshwarkar; Ken Mackie
Journal:  Mol Pharmacol       Date:  2014-08-08       Impact factor: 4.436

4.  Enabling Anyone to Translate Clinically Relevant Ideas to Therapies.

Authors:  Sean Ekins; Natalie Diaz; Julia Chung; Paul Mathews; Aaron McMurtray
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

Review 5.  The role of brain tumor advocacy groups.

Authors:  Michele Rhee; Paulius Mui; Carl Cadogan; Jonny Imerman; Sarah Lindsell; Lainey Titus Samant
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

6.  A dynamic map for learning, communicating, navigating and improving therapeutic development.

Authors:  John Wagner; Andrew M Dahlem; Lynn D Hudson; Sharon F Terry; Russ B Altman; C Taylor Gilliland; Christopher DeFeo; Christopher P Austin
Journal:  Nat Rev Drug Discov       Date:  2017-12-22       Impact factor: 84.694

Review 7.  Approaches to in vitro tissue regeneration with application for human disease modeling and drug development.

Authors:  Mohammad R Ebrahimkhani; Carissa L Young; Douglas A Lauffenburger; Linda G Griffith; Jeffrey T Borenstein
Journal:  Drug Discov Today       Date:  2014-05-02       Impact factor: 7.851

Review 8.  Knowledge-based approaches to drug discovery for rare diseases.

Authors:  Vinicius M Alves; Daniel Korn; Vera Pervitsky; Andrew Thieme; Stephen J Capuzzi; Nancy Baker; Rada Chirkova; Sean Ekins; Eugene N Muratov; Anthony Hickey; Alexander Tropsha
Journal:  Drug Discov Today       Date:  2021-10-27       Impact factor: 8.369

9.  Disease advocacy organizations catalyze translational research.

Authors:  Sharon F Terry
Journal:  Front Genet       Date:  2013-06-04       Impact factor: 4.599

Review 10.  Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery.

Authors:  Douglas B Kell; Royston Goodacre
Journal:  Drug Discov Today       Date:  2013-07-26       Impact factor: 7.851
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.